Understanding discrepancies in trial-level surrogacy of LDL-cholesterol reduction for cardiovascular risk: a methodological appraisal and updated meta-regression

29 August 2026 (09:15 - 09:45)
Organised by: Logo
Congress Presentation Part of: Therapeutic advancements in lipid-lowering pharmacotherapy Lipid-Lowering Agents ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology